Related Experiment Video
Updated: May 8, 2026
09:41
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
Published on: July 19, 2019
Paroxysmal ataxia and dysarthria in multiple sclerosis
R Iorio1, F Capone1, D Plantone1
1Institute of Neurology, Department of Neurosciences, Catholic University, L.go F.Vito, 1, Rome 00168, Italy.
Summary
Transient neurological symptoms like ataxia and dysarthria can occur in multiple sclerosis (MS). This case study shows carbamazepine effectively treated these paroxysmal symptoms during MS relapse recovery.
Area of Science:
- Neurology
- Neuroimmunology
Background:
- Paroxysmal ataxia and dysarthria are transient neurological symptoms within the spectrum of multiple sclerosis (MS).
- Early identification of these symptoms is crucial as they may be the sole indicator of an MS relapse.
- Symptomatic treatments can significantly improve patient outcomes.
Observation:
- A patient recovering from a multiple sclerosis relapse developed paroxysmal ataxia and dysarthria.
- These transient neurological disturbances were documented via video imaging.
- The patient's symptoms were observed during the recovery phase of the MS relapse.
Findings:
- Carbamazepine treatment led to the complete resolution of paroxysmal ataxia and dysarthria in the patient.
- This suggests carbamazepine is an effective symptomatic therapy for these specific neurological disturbances in MS.
- The video documentation provides objective evidence of the symptom reversal.
Implications:
- Prompt recognition and symptomatic treatment of paroxysmal neurological symptoms in MS can improve quality of life.
- Carbamazepine represents a viable therapeutic option for managing paroxysmal ataxia and dysarthria in multiple sclerosis patients.
- This case highlights the importance of considering symptomatic management for transient neurological deficits during MS relapses.
Related Concept Videos
01:19Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
01:12Alterations in Muscle Tone ll
Alterations in muscle tone are common manifestations of neurological disorders and reflect dysfunction within different nervous system regions. Spasticity, paratonia, and dystonia represent distinct forms of hypertonia, each with unique mechanisms, clinical features, and diagnostic importance.CharacteristicsSpasticity happens from upper motor neuron lesions and is characterized by velocity-dependent resistance to passive movement. Clinical features include:Exaggerated deep tendon reflexesClonus...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:11Alterations in Muscle Tone lll
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:26Cross-bridge Cycle
As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.